- Home
- TXG vs RNP Comparison
TXG vs RNP Comparison
Compare TXG & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- RNP
- Stock Information
- Founded
- TXG 2012
- RNP 2003
- Country
- TXG United States
- RNP United States
- Employees
- TXG N/A
- RNP N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- RNP Investment Managers
- Sector
- TXG Industrials
- RNP Finance
- Exchange
- TXG Nasdaq
- RNP Nasdaq
- Market Cap
- TXG 1.3B
- RNP 1.1B
- IPO Year
- TXG 2019
- RNP N/A
- Fundamental
- Price
- TXG $14.11
- RNP $22.66
- Analyst Decision
- TXG Buy
- RNP
- Analyst Count
- TXG 12
- RNP 0
- Target Price
- TXG $14.13
- RNP N/A
- AVG Volume (30 Days)
- TXG 3.7M
- RNP 117.6K
- Earning Date
- TXG 08-07-2025
- RNP 01-01-0001
- Dividend Yield
- TXG N/A
- RNP 7.94%
- EPS Growth
- TXG N/A
- RNP N/A
- EPS
- TXG N/A
- RNP N/A
- Revenue
- TXG $624,662,000.00
- RNP N/A
- Revenue This Year
- TXG N/A
- RNP N/A
- Revenue Next Year
- TXG $5.69
- RNP N/A
- P/E Ratio
- TXG N/A
- RNP N/A
- Revenue Growth
- TXG N/A
- RNP N/A
- 52 Week Low
- TXG $6.78
- RNP $15.52
- 52 Week High
- TXG $24.76
- RNP $21.27
- Technical
- Relative Strength Index (RSI)
- TXG 68.91
- RNP 55.70
- Support Level
- TXG $11.45
- RNP $22.31
- Resistance Level
- TXG $14.16
- RNP $22.99
- Average True Range (ATR)
- TXG 0.71
- RNP 0.24
- MACD
- TXG 0.08
- RNP -0.04
- Stochastic Oscillator
- TXG 93.01
- RNP 50.74
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances.